Using machine learning to optimise antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii

OBJECTIVE: Increased rates of carbapenem-resistant Acinetobacter baumannii has forced clinicians to rely upon last-line agents, such as the polymyxins, or empiric, un-optimized combination therapy. Therefore, the objectives of this study were to: (1) evaluate the in vitro pharmacodynamics of meropen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Microbiol Infect
Autors principals: Smith, Nicholas M., Lenhard, Justin R., Boissonneault, Katie Rose, Landersdorfer, Cornelia B., Bulitta, Jürgen B., Holden, Patricia N., Forrest, Alan, Nation, Roger L., Li, Jian, Tsuji, Brian T.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7587610/
https://ncbi.nlm.nih.gov/pubmed/32061797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmi.2020.02.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars